Home / Browse Journals & Books / Annals of Nephrology / Archive / Volume 3, Issue 1
COMMENTARY Pages 28-30
Abstract: Stem cell-based therapy offers an alternative treatment for chronic kidney diseases, including acute or chronic renal failure, diabetic nephropathy, polycystic kidney diseases and renal transplantation. Most studies have focused on endothelial progenitor cells or mesenchymal stem cells (MSCs).
| | |
RESEARCH ARTICLE Pages 24-27
Abstract: A retrospective 5-year review was performed on 11 children (mean age of 14.6 yrs (8.1-18 yrs), 8 boys and 3 girls) who had SD or FRNS from April 2009 to April 2014. All patients were in remission for at least 4 weeks before the start of Rituximab, and they received two doses of intravenous rituximab (500 mg).